Zhang B, Bao H, Li Z, Chen J, et al. Continuing immune checkpoint inhibitors after progression: Real-world patterns of care and outcomes in second-line treatment for extensive-stage small-cell lung cancer. Lung Cancer 2024;199:108021.
PMID: 39705825